Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancer
Keizō Sugimachi(Kyushu University), Yasumasa Monden(Hokkaido University Hospital), Kazuyuki EIDA(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Eiji KONAGA(Iwakuni Medical Center), Shoichihi Noda(Beppu Medical Center), Michio Ogawa(Kumamoto University), Noriaki Tanaka(The University of Texas MD Anderson Cancer Center), Masazumi Maeda(Kagawa University), Yasuo Nomura(Hokkaido University Hospital), Kiyohiko Dohi(Hiroshima University), Yoshihiko Maehara(Kyushu University), Tetsuya Toge(Hiroshima University), Kohei Akazawa(Niigata University)
Cited by 10
Related Papers
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238
Inhaled Granulocyte/Macrophage–Colony Stimulating Factor as Therapy for Pulmonary Alveolar Proteinosis
|American Journal of Respiratory and Critical Care Medicine|2010|228